(Q37785169)

23 August 2017

title

Management of arterial blood pressure in acute ischemic and hemorrhagic stroke (English)

1 reference

23 August 2017

Management of Arterial Blood Pressure in Acute Ischemic and Hemorrhagic Stroke (English)

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

6 July 2024

author name string

Sara Hocker

1

1 reference

23 August 2017

Sarkis Morales-Vidal

2

1 reference

23 August 2017

Michael J. Schneck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816267

6 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816267

6 July 2024

publication date

14 July 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0733861910000599?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

https://api.elsevier.com/content/article/PII:S0733861910000599?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

6 July 2024

1 reference

23 August 2017

volume

28

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

863-886

1 reference

Prevention of stroke recurrence

23 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Epidemiology of uncontrolled hypertension in the United States

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Randomised trial of treatment of hypertension in elderly patients in primary care

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood pressure and clinical outcomes in the International Stroke Trial

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Autoregulation of brain circulation in severe arterial hypertension.

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cerebral circulation under normal and pathologic conditions

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Morphometric study on cerebral vessels in spontaneously hypertensive rats

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Protection of cerebral vessels by sympathetic nerves and vascular hypertrophy

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Upper limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cerebrovascular aspects of antihypertensive treatment

6 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension.

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Thresholds in cerebral ischemia - the ischemic penumbra

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Viability thresholds and the penumbra of focal ischemia

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

A transient hypertensive opening of the blood-brain barrier can lead to brain damage. Extravasation of serum proteins and cellular changes in rats subjected to aortic compression

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Regional cerebral blood flow in patients with ruptured intracranial aneurysms

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cerebral function, metabolism and blood flow. News and trends from the VIIIth international CBF symposium in Copenhagen, June 1977.

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effect of age on cerebral blood flow velocity and incidence of vasospasm after aneurysmal subarachnoid hemorrhage

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

6 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Prophylactic Hypervolemia without Calcium Channel Blockers in Early Aneurysm Surgery

6 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm.

6 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a

6 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cerebral blood flow after experimental basal ganglia hemorrhage.

6 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats

6 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage

6 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study

6 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Brain blood volume, flow, and oxygen utilization measured with 15O radiotracers and positron emission tomography: revised metabolic computations

6 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?

6 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement.

6 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra.

6 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia

6 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis

6 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Evolving stroke and the ischemic penumbra

6 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

SERIAL OBSERVATIONS ON THE PATHOPHYSIOLOGY OF ACUTE STROKE

6 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts

6 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Progressive derangement of periinfarct viable tissue in ischemic stroke.

6 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke

6 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography

6 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.

6 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood Pressure After Stroke

6 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood pressure during the first minutes of focal cerebral ischemia

6 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety.

6 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

A pilot study of drug-induced hypertension for treatment of acute stroke

6 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Guidelines for the Early Management of Adults With Ischemic Stroke

6 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Tissue plasminogen activator for acute ischemic stroke

6 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome

6 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

6 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration.

6 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).

6 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension

6 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Stroke precipitated by moderate blood pressure reduction

6 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood pressure management in acute stroke

6 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

6 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The prognostic value of admission blood pressure in patients with acute stroke

6 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

High blood pressure in acute stroke and subsequent outcome: a systematic review

6 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

6 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Hypertension and stroke--rationale behind the ACCESS trial. Acute Candesartan Cilexetil Evaluation in Stroke Survivors.

6 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

6 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

6 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

6 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

6 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

6 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis

6 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

6 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Chlorthalidone: has it always been the best thiazide-type diuretic?

6 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

6 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region

6 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

6 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

6 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

6 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Prevention of stroke in patients with hypertension

6 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

6 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

6 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

6 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Telmisartan, ramipril, or both in patients at high risk for vascular events

6 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

6 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

6 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

6 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial

6 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

6 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Orthostatic fall in blood pressure in the very elderly hypertensive: results from the hypertension in the very elderly trial (HYVET) - pilot

6 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Telmisartan to prevent recurrent stroke and cardiovascular events

6 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management

6 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The effects of treating hypertension following aneurysmal subarachnoid hemorrhage

6 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

6 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Determinants of intracerebral hemorrhage growth: an exploratory analysis

6 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Recombinant activated factor VII for acute intracerebral hemorrhage

6 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage

6 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The ICH score: a simple, reliable grading scale for intracerebral hemorrhage

6 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model

6 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage.

6 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage

6 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage

6 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies

6 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines

6 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

6 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage

6 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design

6 July 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke.

6 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Treating Hypertension in Acute Stroke

6 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke

6 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Effect of intravenous nimodipine on blood pressure and outcome after acute stroke

6 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke.

6 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Use of antihypertensive agents in the management of patients with acute ischemic stroke

6 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Blood pressure and vessel recanalization in the first hours after ischemic stroke.

6 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up

6 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up

6 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

The treatment of brain ischemia with vasopressor drugs.

6 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke

6 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke

6 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.021

6 July 2024

Identifiers

1 reference

23 August 2017

1 reference